Viewing nowGilect 0.5 mg (Rasagiline Mesylate)
Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

MFDS item code 201907386 · Approved 2019.10.22 · Insurance code 643903730
Treatment of idiopathic Parkinson's disease
This medication is used in patients with idiopathic Parkinson's disease. Initially, it can be used alone or as an adjunct to dopamine agonists to relieve symptoms. It is also administered as an adjunct during levodopa therapy when motor fluctuations occur, assisting in managing symptoms. This effectively improves motor function decline associated with Parkinson's disease.
This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended starting dose for patients taking levodopa is 0.5mg once daily. If well tolerated but an adequate clinical response is not achieved, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.
This medication should not be used by patients allergic to any of its ingredients. It should also not be administered to those currently taking or who have recently stopped taking other MAO inhibitors or certain analgesics and cough suppressants. It is not safe to use this medication in patients with moderate or severe liver dysfunction. Care should be taken as various side effects such as cold, headache, depression, dizziness, skin rash, etc., may appear while taking this medication. Especially in Parkinson's disease patients, mental symptoms such as hallucinations or confusion may occur. This medication has the potential for drug interactions, so it is essential to inform healthcare professionals about any other medications being taken. Caution is advised when driving or operating machinery due to potential drowsiness or sudden sleepiness. Pregnant or nursing women should consult a physician before using this medication. It is recommended not to use this medication in children or adolescents under 18 years of age as safety and effectiveness have not been established. Severe side effects may occur in the case of an overdose, so it is essential to adhere to the prescribed dosage and regimen. This medication should be stored out of reach of children and kept at an appropriate temperature.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. The appropriate storage temperature is a cool place between 1 and 25 degrees Celsius.
White or nearly white round tablets
30 tablets/box [(10 tablets/PTP X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRasagiline Mesylate 0.78mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Hana Lundbeck Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Korea Lundbeck Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.